Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 2, 2026
Mar. 2, 2026
The Human Acellular Dermis Market is projected to grow to $2.27 billion by 2030
Indeterminate
EIN Presswire
Mar. 2, 2026
The Human Osteoblasts Market is projected to attain a value of US $53.09 billion by 2030.
Indeterminate
EIN Presswire
Mar. 2, 2026
High-Throughput Screening Services Market Report: Analysis of Competition and Future Outlook
Indeterminate
EIN Presswire
Mar. 2, 2026
DigitalXForce Shapes Industry Dialogue on Trust, Risk, and Security in the AI Era
Indeterminate
EIN Presswire
Mar. 2, 2026
KFSH Performs Stereoelectroencephalography on a Toddler Under the Age of Two
Indeterminate
EIN Presswire
Mar. 2, 2026
Adopting Care Management Platforms: Strategic Advantages in the ACCESS Model Revolution
Indeterminate
EIN Presswire
Mar. 2, 2026
Psychotherapy Works: A Private Practice To Help Individuals in Little Rock, AR
Indeterminate
EIN Presswire
Mar. 2, 2026
Alignment Healthcare Announces Secondary Offering
Indeterminate
GlobeNewswire
Mar. 2, 2026
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
Indeterminate
GlobeNewswire
Mar. 2, 2026
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 2, 2026
Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
Indeterminate
GlobeNewswire
Mar. 2, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 2, 2026
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Indeterminate
GlobeNewswire
Mar. 2, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire